🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Although multiple studies have suggested that treatment with ranibizumab is...
Status
Completed
Location
Retina Associates
Start Date
2012-08
Trial ID
NCT01627249
Central and branch retinal vein occlusions are major causes of visual loss....
Status
Completed
Location
Wilmer Eye Institute
Start Date
2006-01
Trial ID
NCT00407355
Treatments Being Tested
Open-label Multicenter, Phase I/II Study comprising three phases (single do...
Status
Completed
Location
Novartis
Start Date
2005-04
Trial ID
NCT00284089
Treatments Being Tested
This study is designed to compare the post injection inflammation and pain ...
Status
Completed
Location
Sierra Eye Associates
Start Date
2015-01
Trial ID
NCT02363621
Treatments Being Tested
Although anti-vascular endothelial growth factor (VEGF) therapy is generall...
Status
Completed
Location
Retina-Vitreous Associates Medical Group
Start Date
2014-02
Trial ID
NCT01945866
Treatments Being Tested
This study is a Phase III, double-masked, multicenter, randomized, sham inj...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00473330
Treatments Being Tested
The purpose of this study is to evaluate the safety, biological activity an...
Status
Completed
Location
Multiple Locations
Start Date
2015-02
Trial ID
NCT02358889
Treatments Being Tested
Ranibizumab is a humanised recombinant monoclonal antibody fragment targete...
Status
Completed
Location
Novartis - 64 sites in 11 countries
Start Date
2006-04
Trial ID
NCT00331864
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of AKB-977...
Status
Completed
Location
Multiple Locations
Start Date
2014-01
Trial ID
NCT02050828
Treatments Being Tested
This study evaluated the safety and efficacy of ranibizumab on retinal edem...
Status
Completed
Location
Novartis
Start Date
2005-10
Trial ID
NCT00284050
Treatments Being Tested